Phoenix Biotech Acquisition Corp.

NASDAQ:PBAX

5.85 (USD) • At close February 14, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

202420222021
Operating Activities:
Net Income -7.29-0.668-0.316
Depreciation & Amortization 1.11700
Deferred Income Tax 000
Stock Based Compensation 0.09700
Change In Working Capital 02.412-0.365
Accounts Receivables 000
Inventory 000
Accounts Payables 1.2811.6390
Other Working Capital 00.774-0.365
Other Non Cash Items 0-2.837-0.016
Operating Cash Flow -5.79-1.092-0.697
Investing Activities:
Investments In Property Plant And Equipment 000
Acquisitions Net 000
Purchases Of Investments 00-178.5
Sales Maturities Of Investments 000
Other Investing Activites 0180.8390
Investing Cash Flow 0180.839-178.5
Financing Activities:
Debt Repayment 000
Common Stock Issued 00180.296
Common Stock Repurchased 0-139.3540
Dividends Paid 000
Other Financing Activities 0.572-138.704180.296
Financing Cash Flow 0.572-138.704180.296
Other Information:
Effect Of Forex Changes On Cash 000
Net Change In Cash -5.21841.0431.099
Cash At End Of Period 1.60142.1421.099